有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-(3,4-difluorophenyl)sulfanyl-N-methyl-N-[(1R)-1-phenylethyl]acetamide | —— | C17H17F2NOS |
|
—— | 4-[(5-Cyclopropyl-4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-2-thiophen-2-yl-1,3-thiazole | —— | C14H14N4S3 |
|
—— | (1S,2R)-2-methyl-N-[3-[4-(2-methylpropyl)-5-methylsulfanyl-1,2,4-triazol-3-yl]propyl]cyclopropane-1-carboxamide | —— | C15H26N4OS |
|
—— | 4-[(1-Cyclopropyltetrazol-5-yl)sulfanylmethyl]-2-(4-fluorophenyl)-1,3-thiazole | —— | C14H12FN5S2 |
|
—— | (2S)-N-(1-methylpyrazol-4-yl)sulfonyl-2-phenylsulfanylbutanamide | —— | C14H17N3O3S2 |
|
—— | 2-[(1R)-1-(1-methylimidazol-2-yl)sulfanylethyl]-5-thiophen-2-yl-1,3,4-oxadiazole | —— | C12H12N4OS2 |
|
—— | (1R,2R)-2-methyl-N-[3-[4-(2-methylpropyl)-5-methylsulfanyl-1,2,4-triazol-3-yl]propyl]cyclopropane-1-carboxamide | —— | C15H26N4OS |
|
—— | (2S)-N-[2-(4-methylphenyl)sulfanylethyl]oxolane-2-carboxamide | —— | C14H19NO2S |
|
—— | 1-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)-2-[1-(thiophen-2-ylmethyl)tetrazol-5-yl]sulfanylethanone | —— | C19H19N5OS2 |
|
—— | 5-[(1-Cyclopropyltetrazol-5-yl)sulfanylmethyl]-3-thiophen-2-yl-1,2,4-oxadiazole | —— | C11H10N6OS2 |
|
—— | N-[2-[[5-benzyl-4-(2-methoxyethyl)-1,2,4-triazol-3-yl]sulfanyl]acetyl]-1-methylpyrrole-2-carboxamide | —— | C20H23N5O3S |
|
—— | 3-(4,6-dimethyl-2-methylsulfanylpyrimidin-5-yl)-N-[(2S)-heptan-2-yl]propanamide | —— | C17H29N3OS |
|
—— | (2R)-N-[2-(4-methylphenyl)sulfanylethyl]oxolane-2-carboxamide | —— | C14H19NO2S |
|
—— | 3-(4,6-dimethyl-2-methylsulfanylpyrimidin-5-yl)-N-[(2R)-heptan-2-yl]propanamide | —— | C17H29N3OS |
|
—— | 4-(1-Cyclopropyltetrazol-5-yl)sulfanyl-2-pyridin-3-ylquinazoline | —— | C17H13N7S |
|
—— | 4-(1-Cyclopropyltetrazol-5-yl)sulfanyl-5,6-dimethyl-2-(pyrrolidin-1-ylmethyl)thieno[2,3-d]pyrimidine | —— | C17H21N7S2 |
|
—— | N-[5-({[(1-cyanocyclohexyl)carbamoyl]methyl}sulfanyl)-1,3,4-thiadiazol-2-yl]-N-cyclopropylpropanamide | —— | C17H23N5O2S2 |
|
—— | 4-(1-Cyclopentyltetrazol-5-yl)sulfanylthieno[2,3-d]pyrimidine | —— | C12H12N6S2 |
|
—— | N-cyclopropyl-N-[5-[2-oxo-2-(1H-pyrrol-2-yl)ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]propanamide | 878238-99-4 | C14H16N4O2S2 |
|
—— | 2-(2,5-difluorophenyl)sulfanyl-N-(pyridin-2-ylmethyl)acetamide | —— | C14H12F2N2OS |
|
—— | 2-(2,5-difluorophenyl)sulfanyl-N-(4-methylpiperazin-1-yl)acetamide | —— | C13H17F2N3OS |
|
—— | 2-(2,5-difluorophenyl)sulfanyl-N-(4-methylpiperazin-4-ium-1-yl)acetamide | —— | C13H18F2N3OS+ |
|
—— | (2S)-N-[(1R)-1-phenylbutyl]-2-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)sulfanyl]propanamide | —— | C19H21N3O2S2 |
|
—— | 2-(4-methylphenyl)sulfanyl-N-(4-methylpiperazin-1-yl)acetamide | —— | C14H21N3OS |
|
—— | 2-(4-fluorophenyl)sulfanyl-N-(4-methylpiperazin-4-ium-1-yl)acetamide | —— | C13H19FN3OS+ |
|
—— | (2R)-N-[(1R)-1-phenylbutyl]-2-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)sulfanyl]propanamide | —— | C19H21N3O2S2 |
|
—— | (2S)-N-[(1S)-1-phenylbutyl]-2-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)sulfanyl]propanamide | —— | C19H21N3O2S2 |
|
—— | (2R)-N-[(1S)-1-phenylbutyl]-2-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)sulfanyl]propanamide | —— | C19H21N3O2S2 |
|
—— | 2-(4-bromophenyl)sulfanyl-N-(4-methylpiperazin-4-ium-1-yl)acetamide | —— | C13H19BrN3OS+ |
|
—— | 2-(2-Tert-butylsulfonylethylsulfanyl)-1-propan-2-ylpyrimidin-4-one | —— | C13H22N2O3S2 |
|
—— | 2-(4-bromo-2-methylphenyl)sulfanyl-N-(4-methylpiperazin-1-yl)acetamide | —— | C14H20BrN3OS |
|
—— | tert-butyl (2R)-4-[5-chloro-6-(1-methylimidazol-2-yl)sulfanylpyridine-3-carbonyl]morpholine-2-carboxylate | —— | C19H23ClN4O4S |
|
—— | (5-Thiophen-2-yl-1,3,4-oxadiazol-2-yl)methyl 2-phenylsulfanylpyridine-3-carboxylate | —— | C19H13N3O3S2 |
|
—— | tert-butyl (2S)-4-[5-chloro-6-(1-methylimidazol-2-yl)sulfanylpyridine-3-carbonyl]morpholine-2-carboxylate | —— | C19H23ClN4O4S |
|
—— | 2-(4-chlorophenyl)sulfanyl-N-(4-methylpiperazin-1-yl)-5-nitrobenzamide | —— | C18H19ClN4O3S |
|
—— | 2-(2-methylphenyl)sulfanyl-N-(4-methylpiperazin-1-yl)acetamide | —— | C14H21N3OS |
|
—— | 2-[(5-cyclohexyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]-1-[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]ethanone | —— | C23H36N4OS |
|
—— | 2-[(1S)-1-(2-fluorophenyl)sulfanylethyl]-5-(4-methylphenyl)-1,3,4-oxadiazole | —— | C17H15FN2OS |
|
—— | 2-(4-methylphenyl)-5-[(1R)-1-(4-methylphenyl)sulfanylethyl]-1,3,4-oxadiazole | —— | C18H18N2OS |
|
—— | 2-[(1S)-1-(2,4-dimethylphenyl)sulfanylethyl]-5-thiophen-2-yl-1,3,4-oxadiazole | —— | C16H16N2OS2 |
|
—— | 2-[(1R)-1-(2-fluorophenyl)sulfanylethyl]-5-(4-methylphenyl)-1,3,4-oxadiazole | —— | C17H15FN2OS |
|
—— | 2-[(1R)-1-(2,4-dimethylphenyl)sulfanylethyl]-5-thiophen-2-yl-1,3,4-oxadiazole | —— | C16H16N2OS2 |
|
—— | 1-(1H-pyrrol-2-yl)-2-[1-(thiophen-2-ylmethyl)tetrazol-5-yl]sulfanylethanone | —— | C12H11N5OS2 |
|
—— | 2-[[(4R)-1,3-dioxan-4-yl]methylsulfanyl]-5-[(5S)-5-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-1,3,4-oxadiazole | —— | C16H20N2O3S2 |
|
—— | 2-(3,4-difluorophenyl)sulfanyl-1-[(2R)-2-thiophen-2-ylpyrrolidin-1-yl]ethanone | —— | C16H15F2NOS2 |
|
—— | 2-(3,4-difluorophenyl)sulfanyl-1-[(2S)-2-thiophen-2-ylpyrrolidin-1-yl]ethanone | —— | C16H15F2NOS2 |
|
—— | 2-(4-methylphenyl)-5-[(1S)-1-(4-methylphenyl)sulfanylethyl]-1,3,4-oxadiazole | —— | C18H18N2OS |
|
—— | (2S)-2-[(5-ethylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]-N-(2-thiophen-2-ylethyl)propanamide | —— | C13H17N3OS4 |
|
—— | 6-methyl-2-[(1S)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]sulfanylpyrimidin-4-amine | —— | C15H15N5OS |
|
—— | 2-(4-fluorophenyl)sulfanyl-N-[(R)-furan-2-yl(phenyl)methyl]acetamide | —— | C19H16FNO2S |
|